The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Aaron Grey - AGP - Analyst
: Hi, good morning, and thank you for the questions. First question for me, just on the international front, so I know the receipt of your EU-GMP
certificate is meaningful, and I believe you mentioned some discussions for some other international opportunities.
So just curious if you could provide any colour in terms of the types of investments or acquisitions you believe are best available to help capitalize
on the growth in the international market, so maybe the geographies or different areas of supply chain to help you capitalize on that.
Thank you.
Question: Aaron Grey - AGP - Analyst
: Thanks for that colour Beena. That was, really, helpful there. Second question for me just in terms of looking at the company on a pro forma basis,
disclosed, within the financial statements, I believe the company would have had more like $98 million in revenue if (multi-Vendor) for the full
quarter, but correct me if I'm wrong there.
So just any colour in terms of the pro forma of a company, particularly on a profitability basis for EBITDA and how that also trended, both sequentially
and year over year just give us a better picture in terms of the trends on a pro forma basis.
Thank you.
Question: Aaron Grey - AGP - Analyst
: Okay great thanks for the call there. I'll jump back in the queue.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
FEBRUARY 11, 2025 / 1:00PM, OGI.TO - Q1 2025 OrganiGram Holdings Inc Earnings Call
Question: Yewon Kang - Canaccord Genuity - Analyst
: Hi, good morning.
Thank you for the question. Just wanted to get your thoughts on the strength of international markets, specifically Germany, and the timing of the
EU GMP certification completion in your Moncton facility.
So obviously good to see that Germany has seen the forex growth in its medical programs since April of last year. But lately we've also seen more
LPs moving into that space, and given that the certification will be completed by spring of this year, how are you thinking about the growth profile
by then versus how it's tracking today?
Do you foresee any headwinds related to oversupply in that market, which was something that we've seen in Israel previously? Just wanted to get
your guys' thoughts on that.
Thank you.
Question: Yewon Kang - Canaccord Genuity - Analyst
: Thanks for the colour, and if I could just shift gears back to the Canadian domestic market, obviously, the new federal election is happening very
soon, I guess just how are you guys thinking about the impacts of the government changing potentially, and, specifically its impacts on the excise
tax reform that has been recommended by the current government's committee going forward.
Question: Yewon Kang - Canaccord Genuity - Analyst
: Thanks for the colour Beena. I'll jump back into the queue.
|
